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Abstract
Background We have assessed the effects of laparoscopic
sleeve gastrectomy (LSG) and biliopancratic diversion with
a duodenal switch (BPDDS) on fatty acid (FA) levels in se-
rum. In particular, we examine the impact of surgery on the
ratio of the FAs eicosapentaenoic acid (EPA) to arachidonic
acid (AA) which impacts, e.g., cardiovascular health. Our hy-
pothesis is that LSG and BPDDS influence the FA levels but
that BPDDS may have a more persistent impact since BPDSS
superimposes intestinal malabsorption on gastric restriction.
Methods Serum samples after overnight fasting were collect-
ed 3 months and 1 day before surgery and 3 days, 3 months,
and 12 months after surgery from 10 BPDDS patients and 23
LSG patients. The levels of 16 FAs were quantified by gas
chromatography. Preoperative and postoperative concentra-
tions of EPA and AA and the ratio of EPA to AAwere com-
pared by Wilcoxon signed-rank test corrected for multiple
testing using false discovery rate.
Results The ratio of EPA/AA at each of the three postopera-
tive sampling points was lower than at the two preoperative
sampling points for BPDDS with p<0.05 after correcting sig-
nificance levels for multiple testing. For LSG, the ratio was
lower with p<0.05 at 3 days and at 3 months after surgery, but
not after 12 months.
Conclusion Both LSG and BPDDS lower the ratio of EPA/
AA significantly and below recommended values, but LSG
patients resurge toward normal values after approximately
12 months, while BPDDS patients do not.
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Introduction
Bariatric surgery may impart sustained weight loss and remis-
sion of comorbidities [1–3]. The biliopancreatic diversion
with duodenal switch (BPDDS) provides a large weight loss
and a high remission rate for metabolic diseases by combining
a reduction of the gastric volume (to create gastric restriction)
with small bowel bypass (to create intestinal malabsorption).
The procedure is not standardized, and different centers use
different combinations of restriction/malabsorption [4]. Lapa-
roscopic sleeve gastrectomy (LSG) was introduced as the first
stage in a two-stage approach on super-obese or high-risk
patients [5] but has later been established as a stand-alone
bariatric procedure [6]. LSG reduces the gastric volume with-
out rerouting the gastrointestinal tract.
Bariatric surgery has potential to adversely alter serum nu-
tritional markers of health. Fatty acid (FA) levels in the blood
may be reduced due to decreased dietary intake after LSG and
BPDDS, or due to malabsorption of lipids after BPDDS. On
the other hand, FA levels may be increased due to input from
reverse cholesterol transport (RCT) of FAs from the patients’
own fat deposits during the weight loss process. The FAs
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stored in the fat deposit are not optimal from a nutritional point
of view, and compensatory measures may be necessary such
as omega-3 supplements. A particular concern is the levels of
eicosapentaenoic acid (EPA) and the ratio of EPA to arachi-
donic acid (AA). Since the pioneering work of Dyerberg et al.
[7] that suggested a link between the low incidence of cardio-
vascular events among Greenland Eskimos and their high lev-
el of serum EPA and high level of the ratio EPA/AA, numer-
ous studies confirmed the associations between low values on
these markers and the development of many diseases [8].
By comparing the FA levels in serum at several time points
during the first year after surgery, we aim at exploring the
effect of restriction (LSG) and malabsorption superimposed
on restriction (BPDDS). In particular, we focus on the levels
of EPA and the ratio of EPA to AA. A cohort of healthy
nonobese individuals recruited from the same region as the
obese is used as controls with the objective to examine if the




Thirty-six morbidly obese ethnic Norwegians of both genders
that fulfilled the criteria for bariatric surgery (BMI >40, or,
BMI >35 and the presence of obesity-related disease) were
recruited for this investigation. Exclusion criteria were alcohol
or drug abuse and active psychosis. Patients with type 2 dia-
betes were selected for BPDDS. Twelve patients were selected
for BPDDS and 24 for LSG, but two of the BPDDS patients
and one LSG patient were excluded because the FA analyses
revealed that they used EPA supplements. Mean and standard
deviation of BMI were 44.4±8.0 and 44.7±3.8 kg/m2 for the
BPDDS and the LSG group, respectively. One hundred thirty-
six healthy nonobesemen and women from the same region in
Norway with BMI 24.5±2.8 kg/m2 were used as controls.
EPA and DHA serum levels determined from the FA analyses
and a validated questionnaire providing information about use
of supplements over the last year [9] were available to elimi-
nate controls using omega-3 supplements. Use of lipid-
lowering agents was another exclusion criterion for the control
group [10].
Blood Sampling and Blood Analyses
Blood samples were collected 3 months before surgery (visit
1), 1 day before surgery (visit 2), 3 days after surgery (visit 3),
and at 3 months (visit 4) and 12 months (visit 5) follow-up.
For BPDDS, three patients did not provide serum at visit 4 and
one at visit 5. For LSG patients, one, three, and five patients
did not provide serum at visits 2, 4, and 5, respectively. All
samples were taken in the morning after overnight fasting.
Serum was obtained according to a standardized protocol
[11] before stored at −80 °C.
Measurement of FA Profiles
The serum samples were worked up and analyzed bymeans of
a minor modifications to the procedure described in Lin et al.
[11]. Total amounts of 16 FAs in each sample were quantified
as micrograms per gram sample.
Statistical Analysis
The dataset with 16 FAs, total fatty acid (TFA), and saturated
fatty acid (SFA) concentrations, and the ratio of EPA/AAwere
subjected to statistical analysis. This dataset includes the ma-
jority of FAs that are considered biologically important except
docosapentaenoic acid (DPA) and 22:5 n-6 which were re-
moved from the analysis due to coelution with major
interferents.
Means and standard deviations were calculated for the two
groups of patients at the five visits. Wilcoxon nonparametric
signed-rank test [12] was applied to assess the statistical sig-
nificance of differences between preoperative FA levels and
levels 1 year after surgery at p=0.05 after correction for mul-
tiple testing by calculating the false discovery rate (FDR) [13].
Furthermore, pair-wise comparisons at all sampling points
were performed for EPA, AA, and the ratio of EPA/AA. A
two-tailed t test [14] was used to compare the omega-3 FA
levels of obese with nonobese subjects.
Correlation coefficients for pairs of visits were used to
study the changes for BPDDS and LSG at the five sampling
points. The analysis was performed by use of Sirius Version
10.0 (Pattern Recognition Systems AS, Bergen, Norway)
[15].
Results
Comparison of Preoperative Serum FA Levels of Obese
with Nonobese
At visit 1, the patients were advised to increase physical ac-
tivity and change to a less carbohydrate-rich andmore protein-
rich diet [6], but this change in lifestyle had no effect on the FA
levels. Thus, for both surgical groups, the FAs were similar
and stable at the preoperative visit 1 and 2 (Table 1). Compar-
ison with the group of nonobese subjects reveals that the
omega-3 FAs are significantly lower in the obese patients than
in the normal. By using a two-tailed t test, the differences
between the obese and nonobese (BPDDS plus LSG) at visit
2 are significant at p<0.0001 for α-linolenic acid (ALA),
p<0.0025 for EPA, and p<0.05 for docosahexaenoic acid
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(DHA). Furthermore, the level of the essential FA linoleic acid
(LA) is lower in the obese with p<0.0001. However, after
correcting for multiple testing, the difference for DHA is not
statistically significant.
Changes in Serum FA Pattern After Surgery
At visit 3, 3 days after surgery, the omega-3 FAs, ALA, and
EPA show strong reduction for both surgical groups
(Table 1). For ALA, the levels increase again from 3 to
12 months for both groups, but for EPA, the reduction con-
tinues after BPDDS, and at 12 months, the reduction from the
preoperative level is almost 50 %. After LSG, EPA increases
from 3 to 12 months after surgery but is still almost 20 %
below the preoperative level. Levels of AA and DHA do not
change significantly except for the BPDDS group at visit 5
where level has decreased approximately 20 %. This is sim-
ilar to the reduction in the level of TFA from 3 to 12 months
in the BPDDS patients, implying that the relative concentra-
tion of DHA in serum is not changed. Nervonic acid (24:1 n-
9) shows an increase in serum concentration 3 months after
surgery in both BPDDS and LSG patients, but in LSG pa-
tients, it is back at baseline values after 1 year. In LSG pa-
tients, Wilcoxon signed-rank test corrected for multiple test-
ing showed no significant differences between visits 2 and 5.
Thus, the FA levels appear normalized or, at least, on a track
back to preoperative levels 1 year after surgery. In the
BPDDS group, however, total fatty acid (TFA) as well as
saturated fatty acid (SFA) and most individual FAs in serum
continue to decrease. The reduction in both TFA and SFA is
approximately 16 %, and a similar decrease is observed for
most of the unsaturated FAs. Individual FAs that are signifi-
cantly different at p=0.05 and p=0.01 1 year after surgery in
BPDDS patients, using Wilcoxon signed-rank test corrected
for multiple testing, are marked with one and two stars, re-
spectively, in Table 1.
Table 1 Mean concentrations of 16 fatty acids sampled at five visits for BPDDS and LSG patients and for a nonobese control group (NCG) with BMI
<30 from the same region as the patients
FA NCG BPDDS LSG
(136) 1 (10) 2 (10) 3 (10) 4 (7) 5 (9) 1 (23) 2 (22) 3 (23) 4 (20) 5 (18)
14:0 44.4 36.1 41.8 20.2 25.6 32.5 45.9 37.4 21.3 26.0 34.8
16:0 909 873 964 977 891 745 943 893 942 915 870
16:1 n-9 16.3 14.1 16.3 11.5 16.3 16.6 16.8 16.5 11.9 14.1 16.4
16:1 n-7 74.8 86.6 104 80.1 102 82.9 108 113 90.7 98.8 80.5
18:0 304 284 302 259 260 207* 322 276 236 253 275
18:1 n-9 831 787 881 908 910 777 875 857 899 877 877
18:1 n-7 58.7 54.5 63.0 68.1 73.0 64.5 62.3 67.5 73.3 72.7 60.2
18:2 n-6 LA 1249 961 959 790 738 648* 1004 920 806 923 1044
18:3 n-3 ALA 31.1 21.2 24.4 12.4 13.6 15.4 24.4 20.5 13.1 15.5 18.2
20:3 n-6 59.3 59.9 61.9 50.7 42.3 44.5 72.6 63.3 48.3 45.8 59.0
20:4 n-6 AA 267 246 268 273 293 212* 269 273 283 322 276
22:0 38.3 38.1 34.9 32.2 25.3 17.9* 39.1 33.6 30.0 34.0 39.8
20:5 n-3 EPA 69.0 47.7 48.5 34.8 32.6 26.8* 43.2 39.4 27.3 29.9 33.2
24:0 38.8 33.6 32.8 26.2 20.3 19.0* 34.2 32.1 26.8 31.1 39.3
24:1 n-9 65.5 52.5 59.1 61.3 85.6 79.4 55.5 57.5 61.5 77.2 64.4
22:6 n-3 DHA 124 97.0 107 109 105 82.1* 95.4 98.8 98.3 104 96.3
SFAa 1334 1265 1375 1315 1222 1021 1384 1272 1256 1259 1258
TFAb 4180 3692 3967 3713 3633 2942 4011 3797 3669 3838 3844
EPA/AAc 0.271 0.211 0.189 0.140 0.115 0.130* 0.166 0.152 0.104 0.101 0.136
Number of serum samples available at each visit is provided in parentheses. Systematic names are used for labeling the FAs. In addition, abbreviations for
the omega-3 FAs are included, i.e., α-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), and abbreviations for two
essential omega-6 FAs namely linoleic acid (LA) and arachidonic acid (AA). FA levels at visits 2 and 5 were compared for both groups of patients using
Wilcoxon sign-rank test. The p values were corrected for multiple testing by calculating false discovery rate (FDR) [13]. FAs showing significant
differences at corrected level p=0.05 are indicated by an asterisk (*) and by two asterisks for p=0.01
a Saturated fatty acids (SFA)
b Total fatty acid (TFA)
c EPA to AA ratio (EPA/AA)
OBES SURG (2016) 26:1735–1742 1737
In order to get a more detailed picture of changes in the FA
pattern after surgery, the correlation coefficients were calcu-
lated between pairs of visits. The samples at visit 2 were used
as baseline for this comparison. Each patient group is consid-
ered separately to account for possible differences in the re-
sponse of the metabolic system after surgery. Figure 1 shows
the correlation patterns between the baseline serum concentra-
tions at visit 2 and the three postoperative visits for the LSG
patients. Three months after surgery (red curve), 14:0, ALA,
20:3 n-6, EPA, and the EPA to AA ratio display large negative
correlations with visit no. 2 implying large reductions in se-
rum levels. One year after surgery (black curve), however,
most of the correlation coefficients are close to zero implying
that the FA concentrations have resurged to preoperative
levels. The exceptions are 16:1 n-7 with reduced levels and
22:0 and 24:0 with increased levels, but none of these changes
are significant when corrected for multiple testing at p=0.05,
and the levels are similar to what is observed in the control
group (Table 1). Figure 2 shows the corresponding plot for the
BPDDS patients. Three months after surgery (red curve), the
impact of surgery appears similar to the observation in the
LSG group: large negative correlation coefficients for 14:0,
LA, ALA, 20:3 n-6, 22:0, EPA, 24:0, and EPA to AA ratio.
EPA shows the strongest negative correlation with visit no. 2
with a correlation of −0.61. However, the pattern after 1 year
(black curve) is distinctly different from the LSG group with
large negative correlation coefficients with visit no. 2 for 16:0,
18:0, LA, ALA, 20:3 n-6, AA, 22:0, EPA, 24:0, DHA, and the
EPA to AA ratio. Thus, instead of returning to preoperative
levels, changes after BPDDS are amplified after 1 year.
Levels of Serum EPA to AA Before and After Surgery
EPA levels decreased immediately after both type of
bariatric surgery (Table 2, visit 3). Over the following
year, EPA levels and the ratio EPA to AA further de-
clined for BPDDS, but after LSG, both EPA and EPA/
AA increased, although levels did not reach the preop-
erative levels. The AA levels in the preoperative and
postoperative serum samples are stable and similar for
Fig. 1 Correlation coefficients
for concentrations of serum FAs
between pairs of visits for LSG
patients (blue represents visits
(2,3), red (2,4), and black (2,5))
1738 OBES SURG (2016) 26:1735–1742
both kinds of surgeries, except for the BPDDS group at
the visit one year after surgery, which shows a consis-
tent decline for all patients. The ratio of EPA to AA
follows the same trend as for EPA levels in the two
patient groups since AA levels are stable. Only visit 5
for the BPDDS patients breaks this pattern by being
stable from visit 4 although EPA level declines. This
is due to the simultaneous drop in AA level which is
relatively larger than the drop in EPA level at visit 5.
Statistical Assessment of Changes in Levels of EPA, AA,
and EPA/AA
Since neither the levels of EPA nor AA change significantly
between the two preoperative visits (Table 2), both visits were
used as baselinemeasurements prior to surgery. Thus, we have
compared the postoperative visits with both the preoperative
visits to obtain a duplicate of p values to assess significance of
changes in the postoperative phase.
Fig. 2 Correlation coefficients
for concentrations of serum FAs
between pairs of visits for
BPDDS patients (blue represents
visits (2,3), red (2,4), and black
(2,5))
Table 2 Serum concentrations of
eicosapentaenoic acid (EPA),
arachidonic acid (AA), and the
ratio of EPA to AA (EPA/AA) for
visits 1–5 (mean±standard
deviation) for the two types of
surgery
Visit EPA/AA EPA AA
BPDDS LSG BPDDS LSG BPDDS LSG
1 0.21±0.10 0.17±0.09 48±20 43±23 246±99 269±84
2 0.19±0.08 0.15±0.07 49±20 39±15 268±80 273±57
3 0.14±0.06 0.10±0.05 35±10 27±7 273±117 283±71
4 0.12±0.04 0.11±0.07 33±9 30±15 293±88 322±97
5 0.13±0.04 0.14±0.08 27±8 33±14 212±51 276±107
Visits 1 and 2 show preoperative levels, and visits 3–5 postoperative levels
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For the BPDDS group, the continuous decline in the ratio
EPA/AA and EPA levels after surgery is significant at p<0.05
after correcting for multiple testing. The only exception is the
comparison of EPA levels just after surgery with the levels
3 months before surgery (Table 3). For AA levels, there is
no statistically significant change except for the levels at visit
5 when we compare with preoperative levels at hospital (visit
2), but comparison with visit 1 provides statistically insignif-
icant, so we refrain from a definite conclusion. For the LSG
patient group, changes in EPA/AA and EPA levels after sur-
gery are similar to our findings for the BPDDS group just after
surgery and 3 months later with p<0.01 for EPA/AA and
p<0.05 for EPAwhether we compare with preoperative levels
at visit 1 or at visit 2. At visit 5, however, the levels are no
longer statistically different from preoperative levels. This
complies with the trend observed in Table 2 for the LSG
group, which implies a resurgence to baseline values of EPA
for this group one year after surgery. AA levels do not show
statistical differences between visits for the LSG group, except
for visit 4 where a statistically significant increase is observed
from preoperative levels (p<0.05 after correcting for multiple
testing).
Discussion
Lower Levels of Omega-3 FAs in Obese than Nonobese
The concentration of the omega-3 FAs ALA, EPA, and DHA,
and the ratio of EPA to AA are significantly lower in the
morbidly obese at baseline than in the nonobese. Furthermore,
the abundant essential fatty acid linoleic acid (LA) is also
significantly lower in the obese than in the nonobese subjects
at baseline. A possible explanation can be different dietary
habits in obese and nonobese adults. However, lower concen-
tration of serum EPA and other polyunsaturated FAs in obese
subjects has been observed also in previous investigations. For
instance, Micallef et al. [16] observed a significant inverse
relationship between BMI and EPA and DHA in cohorts of
normal, overweight, and obese adults (BMI=33.6±2.7). They
proposed increased oxidative stress in obese subjects as an
explanation for the reduction of polyunsaturated FAs. At base-
line, the EPA to AA ratio for most of the morbidly obese
patients in our study is above the recommended level of the
World Health Organization (WHO) of 0.1–0.2 but below the
recommended value of 0.2–0.3 in Japan [17].
Postoperative Levels of FAs
The first year after bariatric surgery is a period of continuous
weight loss. During the weight reduction process, energy con-
sumption and body maintenance from dietary intake are sup-
plemented by fat from the fat deposits. This fat transport af-
fects the serum concentration of FAs since stored fat differs in
composition from dietary fat. Although the composition of
FAs in the fat deposits of human depends on diet and therefore
may vary between populations, they are generally dominated
by saturated, monounsaturated, and diunsaturated FAs with 16
and 18 carbon chains. For a Dutch general population of age
19–69, Geerling et al. [18] found the following approx. mean
composition in adipose tissue for the most abundant FAs: 18:1
n-9 (42 %), 16:0 (19 %), 18:2 n-6 (15–16 %), 16:1 n-7
(5.5 %), 18:0 (3.6 %), and 18:1 n-7 (2 %). These percentages
may be representative for Norwegians too, but the deposited
fat of morbidly obese may be different from nonobese as ob-
served for the baseline concentrations of EPA, ALA, DHA,
and LA in serum. However, the serum levels of the other FAs
of the two cohorts (Table 1) imply no significant differences at
Table 3 Estimated p values for serum concentrations of EPA and AA
and the ratio EPA/AA using Wilcoxon signed-rank test [12] to compare
pairs of visits
Visit EPA/AA EPA AA
BPDDS LSG BPDDS LSG BPDDS LSG
(1,2) 0.401 0.596 0.589 0.308 0.250 0.749
(1,3) 0.030* <0.001** 0.078 0.002** 0.063 0.254
(1,4) 0.020* 0.005** 0.020* 0.050 0.254 0.008*
(1,5) 0.023* 0.271 0.017* 0.174 0.091 0.889
(2,3) 0.005* <0.001** 0.039* <0.001** 0.589 0.208
(2,4) 0.031* 0.004** 0.032* 0.008* 0.897 0.006*
(2,5) 0.008* 0.250 0.008* 0.105 0.008* 0.190
By correcting the p values for multiple testing using FDR [13] and com-
paring the three postoperative visits with visit 1, and similarly comparing
the postoperative visits with visit 2, the results for corrected significance
level p=0.05 and p=0.01 are indicated by one and two asterisks,
respectively
Fig. 3 Percent total weight loss (%TWL) during preoperative (-3–0) and
postoperative (0–12, 0–3, and 3–12 months) phases for BPDDS (n=10)
and LSG (n=23) patient groups
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baseline. Thus, assuming that the serum levels roughly mirror
the composition of the adipose tissue, obese and nonobese
subjects appear similar for most of the abundant FAs at base-
line. This hypothesis finds support in Table 1 which shows
that the concentrations of the abundant FAs in serum are rel-
atively stable during the weight loss process after surgery,
especially for the LSG patients. For the BPDDS patients,
16:0 and 18:2 n-6 (LA) in serum gradually decline after sur-
gery despite being abundant in adipose tissue. Of the omega-3
FAs, ALA constitutes approx. 0.7–1.1 % in adipose tissue,
while AA and DHA constitute 0.3–0.5 and 0.1–0.2 %, respec-
tively, and EPA is present in even lower amounts [18, 19]. The
decline of EPA and ALA after surgery is probably the result of
the reduced dietary intake accompanying the gastric restric-
tion. The question is why this is not happening also for the
polyunsaturated FAs DHA and AA. This observation is attrib-
uted to the reduction of muscle mass accompanying the
weight reduction process. Both DHA and AA are abundant
in muscle tissue constituting approx. 3 and 12%, respectively,
of the muscle mass [19].
FA Profiles and Weight Loss After BPDDS and LSG
There is a noticeable difference in the dynamics of metabolic
changes between LSG and BPDDS surgery. In LSG patients,
the FA levels seem to normalize approximately one year after
surgery, while in BPDDS patients, the levels at 3 and
12 months imply an accelerated change. This observation
may be due to malabsorption after BPDDS since this surgery
also includes small bowel bypass leading to a more persistent
weight reduction process (Fig. 3). One year after surgery, the
% total weight loss (TWL) is 49 % in the BPDDS group and
33 % for the LSG group. Figure 3 shows that this difference
increases during the last 9 months with 30 % TWL in the
BPDDS group compared to 19 % in the LSG group. This
may explain the differences in FA levels for the two groups
after one year.
Conclusions
Bariatric surgery has a profound effect on serum FA levels
with ALA and EPA being reduced by 30–40 % from already
low levels during the first year after surgery. The storage ca-
pacity of omega-3 FAs in adipose tissue is limited, so these
FAs have to be supplied from continuous dietary intake.While
FAs resurge toward normal levels for LSG patients, the impact
appears lasting for BPDDS patients. Malabsorption may ex-
plain the persistent low levels of EPA and ALA in addition to
a more enduring weight loss process. Omega-3 supplements
should probably be recommended routinely after bariatric sur-
gery until the weight has stabilized and long-term endpoints
such as adverse cardiovascular events should be monitored for
BPDDS patients. Longer follow-up period is needed in order
to unambiguously establish if the FAs reach normal values
after surgery.
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